The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register, Annals of the Rheumatic Diseases, vol.71, issue.6, pp.869-874, 2011. ,
DOI : 10.1136/annrheumdis-2011-200622
Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists, Annals of the Rheumatic Diseases, vol.64, issue.10, pp.1421-1426, 2005. ,
DOI : 10.1136/ard.2004.033993
Rheumatoid arthritis and cancer risk, European Journal of Cancer, vol.32, issue.10, pp.1753-1757, 1996. ,
DOI : 10.1016/0959-8049(96)00210-9
Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis, Annals of the Rheumatic Diseases, vol.70, issue.11, pp.1895-1904, 2011. ,
DOI : 10.1136/ard.2010.149419
Updated meta-analysis of non-melanoma skin cancer rates reported from prospective observational studies in patients treated with tumour necrosis factor inhibitors, Annals of the Rheumatic Diseases, vol.71, issue.12, p.23014259, 2012. ,
DOI : 10.1136/annrheumdis-2012-202478
Biologic treatment of rheumatoid arthritis and the risk of malignancy: Analyses from a large US observational study, Arthritis & Rheumatism, vol.92, issue.9, pp.2886-2895, 2007. ,
DOI : 10.1002/art.22864
Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data, Pharmacoepidemiology and Drug Safety, vol.32, issue.10, pp.119-130, 2011. ,
DOI : 10.1002/pds.2046
Anti-TNF therapy and risk of skin cancer, data from the Swedish ARTIS Registry, Ann Rheum Dis, vol.68, p.423, 1998. ,
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA), Annals of the Rheumatic Diseases, vol.71, issue.1, pp.62-68, 2014. ,
DOI : 10.1136/annrheumdis-2013-204223
TNF alpha antagonist therapy and safety monitoring, Joint Bone Spine, vol.78, issue.111, pp.15-185, 2011. ,
DOI : 10.1016/S1297-319X(11)70001-X
URL : https://hal.archives-ouvertes.fr/hal-00618537
Efficacy of a general practitioner training campaign for early detection of melanoma in France, British Journal of Dermatology, vol.157, issue.5 Suppl. 1, pp.123-129, 2014. ,
DOI : 10.1111/bjd.12585
Reducing mortality in individuals at high risk for advanced melanoma through education and screening, Journal of the American Academy of Dermatology, vol.65, issue.5, pp.587-594, 2011. ,
DOI : 10.1016/j.jaad.2011.05.045